Blood - PowerPoint PPT Presentation

1 / 132
About This Presentation
Title:

Blood

Description:

Oxygen (O2) and nutrients diffuse across capillary walls and enter tissues ... Color varies from scarlet to dark red. The pH of blood is 7.35 7.45. Temperature is 38 ... – PowerPoint PPT presentation

Number of Views:179
Avg rating:3.0/5.0
Slides: 133
Provided by: marcuslash
Category:
Tags: blood | scarlet

less

Transcript and Presenter's Notes

Title: Blood


1
Chapter 16
  • Blood

2
Overview of Blood Circulation
  • Blood leaves the heart via arteries that branch
    repeatedly until they become capillaries
  • Oxygen (O2) and nutrients diffuse across
    capillary walls and enter tissues
  • Carbon dioxide (CO2) and wastes move from tissues
    into the blood

3
Overview of Blood Circulation
  • Oxygen-deficient blood leaves the capillaries and
    flows in veins to the heart
  • This blood flows to the lungs where it releases
    CO2 and picks up O2
  • The oxygen-rich blood returns to the heart

4
Composition of Blood
  • Blood is the bodys only fluid tissue
  • It is composed of liquid plasma and formed
    elements
  • Formed elements include
  • Erythrocytes, or red blood cells (RBCs)
  • Leukocytes, or white blood cells (WBCs)
  • Platelets
  • Hematocrit the percentage of RBCs out of the
    total blood volume

5
Components of Whole Blood
Figure 16.1
6
Physical Characteristics and Volume
  • Blood is a sticky, opaque fluid with a metallic
    taste
  • Color varies from scarlet to dark red
  • The pH of blood is 7.357.45
  • Temperature is 38?C
  • Blood accounts for approximately 8 of body
    weight
  • Average volume 56 L for males, and 45 L for
    females

7
Functions of Blood
  • Blood performs a number of functions dealing
    with
  • Substance distribution
  • Regulation of blood levels of particular
    substances
  • Body protection

8
Distribution
  • Blood transports
  • Oxygen from the lungs and nutrients from the
    digestive tract
  • Metabolic wastes from cells to the lungs and
    kidneys for elimination
  • Hormones from endocrine glands to target organs

9
Regulation
  • Blood maintains
  • Appropriate body temperature by absorbing and
    distributing heat
  • Normal pH in body tissues using buffer systems
  • Adequate fluid volume in the circulatory system

10
Protection
  • Blood prevents blood loss by
  • Activating plasma proteins and platelets
  • Initiating clot formation when a vessel is broken
  • Blood prevents infection by
  • Synthesizing and utilizing antibodies
  • Activating complement proteins
  • Activating WBCs to defend the body against
    foreign invaders

11
Blood Plasma
  • Blood plasma contains over 100 solutes,
    including
  • Proteins albumin, globulins, clotting proteins,
    and others
  • Lactic acid, urea, creatinine
  • Organic nutrients glucose, carbohydrates, amino
    acids
  • Electrolytes sodium, potassium, calcium,
    chloride, bicarbonate
  • Respiratory gases oxygen and carbon dioxide

12
Formed Elements
  • Erythrocytes, leukocytes, and platelets make up
    the formed elements
  • Only WBCs are complete cells
  • RBCs have no nuclei or organelles, and platelets
    are just cell fragments
  • Most formed elements survive in the bloodstream
    for only a few days
  • Most blood cells do not divide but are renewed by
    cells in bone marrow

13
Erythrocytes (RBCs)
  • Biconcave discs, anucleate, essentially no
    organelles
  • Filled with hemoglobin (Hb), a protein that
    functions in gas transport
  • Contain the plasma membrane protein spectrin and
    other proteins that
  • Give erythrocytes their flexibility
  • Allow them to change shape as necessary

14
Erythrocytes (RBCs)
Figure 16.3
15
Components of Whole Blood
Figure 16.2
16
Erythrocytes (RBCs)
  • Erythrocytes are an example of the
    complementarity of structure and function
  • Structural characteristics contribute to its gas
    transport function
  • Biconcave shape has a huge surface area relative
    to volume
  • Erythrocytes are more than 97 hemoglobin
  • ATP is generated anaerobically, so the
    erythrocytes do not consume the oxygen they
    transport

17
Erythrocyte Function
  • RBCs are dedicated to respiratory gas transport
  • Hb reversibly binds with oxygen and most oxygen
    in the blood is bound to Hb
  • Hb is composed of the protein globin, made up of
    two alpha and two beta chains, each bound to a
    heme group
  • Each heme group bears an atom of iron, which can
    bind to one oxygen molecule
  • Each Hb molecule can transport four molecules of
    oxygen

18
Structure of Hemoglobin
Figure 16.4
19
Hemoglobin (Hb)
  • Oxyhemoglobin Hb bound to oxygen
  • Oxygen loading takes place in the lungs
  • Deoxyhemoglobin Hb after oxygen diffuses into
    tissues (reduced Hb)
  • Carbaminohemoglobin Hb bound to carbon dioxide
  • Carbon dioxide loading takes place in the tissues

20
Production of Erythrocytes
  • Hematopoiesis blood cell formation
  • Hematopoiesis occurs in the red bone marrow of
    the
  • Axial skeleton and girdles
  • Epiphyses of the humerus and femur
  • Hemocytoblasts give rise to all formed elements

21
Production of Erythrocytes Erythropoiesis
  • A hemocytoblast is transformed into a
    proerythroblast
  • Proerythroblasts develop into early erythroblasts
  • The developmental pathway consists of three
    phases
  • 1 ribosome synthesis in early erythroblasts
  • 2 Hb accumulation in late erythroblasts and
    normoblasts
  • 3 ejection of the nucleus from normoblasts and
    formation of reticulocytes
  • Reticulocytes then become mature erythrocytes

22
Production of Erythrocytes Erythropoiesis
  • A hemocytoblast is transformed into a
    proerythroblast
  • Proerythroblasts develop into early erythroblasts

23
Production of Erythrocytes Erythropoiesis
  • The developmental pathway consists of three
    phases
  • 1 ribosome synthesis in early erythroblasts
  • 2 Hb accumulation in late erythroblasts and
    normoblasts
  • 3 ejection of the nucleus from normoblasts and
    formation of reticulocytes
  • Reticulocytes then become mature erythrocytes

24
Production of Erythrocytes Erythropoiesis
Figure 16.5
25
Regulation and Requirements for Erythropoiesis
  • Circulating erythrocytes the number remains
    constant and reflects a balance between RBC
    production and destruction
  • Too few RBCs leads to tissue hypoxia
  • Too many RBCs causes undesirable blood viscosity
  • Erythropoiesis is hormonally controlled and
    depends on adequate supplies of iron, amino
    acids, and B vitamins

26
Hormonal Control of Erythropoiesis
  • Erythropoietin (EPO) release by the kidneys is
    triggered by
  • Hypoxia due to decreased RBCs
  • Decreased oxygen availability
  • Increased tissue demand for oxygen
  • Enhanced erythropoiesis increases the
  • RBC count in circulating blood
  • Oxygen carrying ability of the blood

27
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Increases O2-carrying ability of blood
Reduces O2 levels in blood
Kidney (and liver to a smaller extent) releases
erythropoietin
Enhanced erythropoiesis increases RBC count
Erythropoietin stimulates red bone marrow
Figure 16.6
28
Erythropoietin Mechanism
Homeostasis Normal blood oxygen levels
Figure 16.6
29
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Figure 16.6
30
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Reduces O2 levels in blood
Figure 16.6
31
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Reduces O2 levels in blood
Kidney (and liver to a smaller extent) releases
erythropoietin
Figure 16.6
32
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Reduces O2 levels in blood
Kidney (and liver to a smaller extent) releases
erythropoietin
Erythropoietin stimulates red bone marrow
Figure 16.6
33
Erythropoietin Mechanism
Imbalance
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Imbalance
Reduces O2 levels in blood
Kidney (and liver to a smaller extent) releases
erythropoietin
Enhanced erythropoiesis increases RBC count
Erythropoietin stimulates red bone marrow
Figure 16.6
34
Erythropoietin Mechanism
Start
Homeostasis Normal blood oxygen levels
Stimulus Hypoxia due to decreased RBC
count, decreased amount of hemoglobin, or
decreased availability of O2
Increases O2-carrying ability of blood
Reduces O2 levels in blood
Kidney (and liver to a smaller extent) releases
erythropoietin
Enhanced erythropoiesis increases RBC count
Erythropoietin stimulates red bone marrow
Figure 16.6
35
Dietary Requirements of Erythropoiesis
  • Erythropoiesis requires
  • Proteins, lipids, and carbohydrates
  • Iron, vitamin B12, and folic acid
  • The body stores iron in Hb (65), the liver,
    spleen, and bone marrow
  • Intracellular iron is stored in protein-iron
    complexes such as ferritin and hemosiderin
  • Circulating iron is loosely bound to the
    transport protein transferrin

36
Fate and Destruction of Erythrocytes
  • The life span of an erythrocyte is 100120 days
  • Old RBCs become rigid and fragile, and their Hb
    begins to degenerate
  • Dying RBCs are engulfed by macrophages
  • Heme and globin are separated and the iron is
    salvaged for reuse

37
Fate and Destruction of Erythrocytes
  • Heme is degraded to a yellow pigment called
    bilirubin
  • The liver secretes bilirubin into the intestines
    as bile
  • The intestines metabolize it into urobilinogen
  • This degraded pigment leaves the body in feces,
    in a pigment called stercobilin

38
Fate and Destruction of Erythrocytes
  • Globin is metabolized into amino acids and is
    released into the circulation
  • Hb released into the blood is captured by
    haptoglobin and phgocytized

39
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Erythropoietin and necessary raw materials in
blood promote erythropoiesis in red bone marrow.
3
New erythrocytes enter bloodstream function
about 120 days.
4
Aged and damaged red blood cells are engulfed
by macrophages of liver, spleen, and bone marrow
the hemoglobin is broken down.
5
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Bilirubin is picked up from blood by liver,
secreted into intestine in bile, metabolized to
stercobilin by bacteria and excreted in feces
Circulation
Food nutrients, including amino acids, Fe,
B12, and folic acid are absorbed from
intestine and enter blood
Raw materials are made available in blood for
erythrocyte synthesis.
6
Figure 16.7
40
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Figure 16.7
41
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Figure 16.7
42
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Erythropoietin and necessary raw materials in
blood promote erythropoiesis in red bone marrow.
3
Figure 16.7
43
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Erythropoietin and necessary raw materials in
blood promote erythropoiesis in red bone marrow.
3
New erythrocytes enter bloodstream function
about 120 days.
4
Figure 16.7
44
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Erythropoietin and necessary raw materials in
blood promote erythropoiesis in red bone marrow.
3
New erythrocytes enter bloodstream function
about 120 days.
4
Aged and damaged red blood cells are engulfed
by macrophages of liver, spleen, and bone marrow
the hemoglobin is broken down.
5
Hemoglobin
Figure 16.7
45
Hemoglobin
Globin
Heme
Figure 16.7
46
Hemoglobin
Globin
Heme
Amino acids
Figure 16.7
47
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Figure 16.7
48
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Figure 16.7
49
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Figure 16.7
50
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Bilirubin is picked up from blood by liver,
secreted into intestine in bile, metabolized to
stercobilin by bacteria and excreted in feces
Figure 16.7
51
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Bilirubin is picked up from blood by liver,
secreted into intestine in bile, metabolized to
stercobilin by bacteria and excreted in feces
Circulation
Food nutrients, including amino acids, Fe,
B12, and folic acid are absorbed from
intestine and enter blood
Figure 16.7
52
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Bilirubin is picked up from blood by liver,
secreted into intestine in bile, metabolized to
stercobilin by bacteria and excreted in feces
Circulation
Food nutrients, including amino acids, Fe,
B12, and folic acid are absorbed from
intestine and enter blood
Raw materials are made available in blood for
erythrocyte synthesis.
6
Figure 16.7
53
Low O2 levels in blood stimulate kidneys to
produce erythropoietin.
1
Erythropoietin levels rise in blood.
2
Erythropoietin and necessary raw materials in
blood promote erythropoiesis in red bone marrow.
3
New erythrocytes enter bloodstream function
about 120 days.
4
Aged and damaged red blood cells are engulfed
by macrophages of liver, spleen, and bone marrow
the hemoglobin is broken down.
5
Hemoglobin
Globin
Heme
Bilirubin
Amino acids
Iron stored as ferritin, hemosiderin
Iron is bound to transferrin and released to
blood from liver as needed for erythropoiesis
Bilirubin is picked up from blood by liver,
secreted into intestine in bile, metabolized to
stercobilin by bacteria and excreted in feces
Circulation
Food nutrients, including amino acids, Fe,
B12, and folic acid are absorbed from
intestine and enter blood
Raw materials are made available in blood for
erythrocyte synthesis.
6
Figure 16.7
54
Erythrocyte Disorders
  • Anemia blood has abnormally low oxygen-carrying
    capacity
  • It is a symptom rather than a disease itself
  • Blood oxygen levels cannot support normal
    metabolism
  • Signs/symptoms include fatigue, paleness,
    shortness of breath, and chills

55
Anemia Insufficient Erythrocytes
  • Hemorrhagic anemia result of acute or chronic
    loss of blood
  • Hemolytic anemia prematurely ruptured RBCs
  • Aplastic anemia destruction or inhibition of
    red bone marrow

56
Anemia Decreased Hemoglobin Content
  • Iron-deficiency anemia results from
  • A secondary result of hemorrhagic anemia
  • Inadequate intake of iron-containing foods
  • Impaired iron absorption
  • Pernicious anemia results from
  • Deficiency of vitamin B12
  • Lack of intrinsic factor needed for absorption of
    B12
  • Treatment is intramuscular injection of B12
    application of Nascobal

57
Anemia Abnormal Hemoglobin
  • Thalassemias absent or faulty globin chain in
    Hb
  • RBCs are thin, delicate, and deficient in Hb
  • Sickle-cell anemia results from a defective
    gene coding for an abnormal Hb called hemoglobin
    S (HbS)
  • HbS has a single amino acid substitution in the
    beta chain
  • This defect causes RBCs to become sickle-shaped
    in low oxygen situations

58
Polycythemia
  • Polycythemia excess RBCs that increase blood
    viscosity
  • Three main polycythemias are
  • Polycythemia vera
  • Secondary polycythemia
  • Blood doping

59
Leukocytes (WBCs)
  • Leukocytes, the only blood components that are
    complete cells
  • Are less numerous than RBCs
  • Make up 1 of the total blood volume
  • Can leave capillaries via diapedesis
  • Move through tissue spaces
  • Leukocytosis WBC count over 11,000 / mm3
  • Normal response to bacterial or viral invasion

60
Percentages of Leukocytes
Figure 16.9
61
Granulocytes
  • Granulocytes neutrophils, eosinophils, and
    basophils
  • Contain cytoplasmic granules that stain
    specifically (acidic, basic, or both) with
    Wrights stain
  • Are larger and usually shorter-lived than RBCs
  • Have lobed nuclei
  • Are all phagocytic cells

62
Neutrophils
  • Neutrophils have two types of granules that
  • Take up both acidic and basic dyes
  • Give the cytoplasm a lilac color
  • Contain peroxidases, hydrolytic enzymes, and
    defensins (antibiotic-like proteins)
  • Neutrophils are our bodys bacteria slayers

63
Eosinophils
  • Eosinophils account for 14 of WBCs
  • Have red-staining, bilobed nuclei connected via a
    broad band of nuclear material
  • Have red to crimson (acidophilic) large, coarse,
    lysosome-like granules
  • Lead the bodys counterattack against parasitic
    worms
  • Lessen the severity of allergies by phagocytizing
    immune complexes

64
Basophils
  • Account for 0.5 of WBCs and
  • Have U- or S-shaped nuclei with two or three
    conspicuous constrictions
  • Are functionally similar to mast cells
  • Have large, purplish-black (basophilic) granules
    that contain histamine
  • Histamine inflammatory chemical that acts as a
    vasodilator and attracts other WBCs
    (antihistamines counter this effect)

65
Agranulocytes
  • Agranulocytes lymphocytes and monocytes
  • Lack visible cytoplasmic granules
  • Are similar structurally, but are functionally
    distinct and unrelated cell types
  • Have spherical (lymphocytes) or kidney-shaped
    (monocytes) nuclei

66
Lymphocytes
  • Account for 25 or more of WBCs and
  • Have large, dark-purple, circular nuclei with a
    thin rim of blue cytoplasm
  • Are found mostly enmeshed in lymphoid tissue
    (some circulate in the blood)
  • There are two types of lymphocytes T cells and B
    cells
  • T cells function in the immune response
  • B cells give rise to plasma cells, which produce
    antibodies

67
Monocytes
  • Monocytes account for 48 of leukocytes
  • They are the largest leukocytes
  • They have abundant pale-blue cytoplasms
  • They have purple-staining, U- or kidney-shaped
    nuclei
  • They leave the circulation, enter tissue, and
    differentiate into macrophages

68
Macrophages
  • Macrophages
  • Are highly mobile and actively phagocytic
  • Activate lymphocytes to mount an immune response

69
Leukocytes
Figure 16.10
70
Summary of Formed Elements
Table 16.2.1
71
Summary of Formed Elements
Table 16.2.2
72
Production of Leukocytes
  • Leukopoiesis is stimulated by interleukins and
    colony-stimulating factors (CSFs)
  • Interleukins are numbered (e.g., IL-1, IL-2),
    whereas CSFs are named for the WBCs they
    stimulate (e.g., granulocyte-CSF stimulates
    granulocytes)
  • Macrophages and T cells are the most important
    sources of cytokines
  • Many hematopoietic hormones are used clinically
    to stimulate bone marrow

73
Formation of Leukocytes
  • All leukocytes originate from hemocytoblasts
  • Hemocytoblasts differentiate into myeloid stem
    cells and lymphoid stem cells
  • Myeloid stem cells become myeloblasts or
    monoblasts
  • Lymphoid stem cells become lymphoblasts
  • Myeloblasts develop into eosinophils,
    neutrophils, and basophils
  • Monoblasts develop into monocytes
  • Lymphoblasts develop into lymphocytes

74
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Lymphoblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Prolymphocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Lymphocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
(e)
Some become
Agranular leukocytes
Granular leukocytes
Some become
Plasma cells
Macrophages (tissues)
Figure 16.11
75
Stem cells
Hemocytoblast
Figure 16.11
76
Stem cells
Hemocytoblast
Myeloid stem cell
Figure 16.11
77
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Figure 16.11
78
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Figure 16.11
79
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Figure 16.11
80
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Figure 16.11
81
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
Agranular leukocytes
Granular leukocytes
Figure 16.11
82
Stem cells
Hemocytoblast
Myeloid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
Agranular leukocytes
Granular leukocytes
Some become
Macrophages (tissues)
Figure 16.11
83
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
Agranular leukocytes
Granular leukocytes
Some become
Macrophages (tissues)
Figure 16.11
84
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Lymphoblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
Agranular leukocytes
Granular leukocytes
Some become
Macrophages (tissues)
Figure 16.11
85
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Lymphoblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Prolymphocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
Agranular leukocytes
Granular leukocytes
Some become
Macrophages (tissues)
Figure 16.11
86
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Lymphoblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Prolymphocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Lymphocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
(e)
Agranular leukocytes
Granular leukocytes
Some become
Macrophages (tissues)
Figure 16.11
87
Stem cells
Hemocytoblast
Myeloid stem cell
Lymphoid stem cell
Committed cells
Myeloblast
Myeloblast
Myeloblast
Lymphoblast
Develop- mental pathway
Promyelocyte
Promyelocyte
Promyelocyte
Promonocyte
Prolymphocyte
Eosinophilic myelocyte
Neutrophilic myelocyte
Basophilic myelocyte
Eosinophilic band cells
Neutrophilic band cells
Basophilic band cells
Monocytes
Lymphocytes
Eosinophils
Neutrophils
Basophils
(a)
(b)
(c)
(d)
(e)
Some become
Agranular leukocytes
Granular leukocytes
Some become
Plasma cells
Macrophages (tissues)
Figure 16.11
88
Leukocytes Disorders Leukemias
  • Leukemia refers to cancerous conditions involving
    WBCs
  • Leukemias are named according to the abnormal
    WBCs involved
  • Myelocytic leukemia involves myeloblasts
  • Lymphocytic leukemia involves lymphocytes
  • Acute leukemia involves blast-type cells and
    primarily affects children
  • Chronic leukemia is more prevalent in older people

89
Leukemia
  • Immature WBCs are found in the bloodstream in all
    leukemias
  • Bone marrow becomes totally occupied with
    cancerous leukocytes
  • The WBCs produced, though numerous, are not
    functional
  • Death is caused by internal hemorrhage and
    overwhelming infections
  • Treatments include irradiation, antileukemic
    drugs, and bone marrow transplants

90
Platelets
  • Platelets are fragments of megakaryocytes with a
    blue-staining outer region and a purple granular
    center
  • Their granules contain serotonin, Ca2, enzymes,
    ADP, and platelet-derived growth factor (PDGF)
  • Platelets function in the clotting mechanism by
    forming a temporary plug that helps seal breaks
    in blood vessels
  • Platelets not involved in clotting are kept
    inactive by NO and prostacyclin

91
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Developmental pathway
Hemocytoblast
Megakaryoblast
Promegakaryocyte
Megakaryocyte
Platelets
Figure 16.12
92
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Hemocytoblast
Figure 16.12
93
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Developmental pathway
Hemocytoblast
Megakaryoblast
Figure 16.12
94
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Developmental pathway
Hemocytoblast
Megakaryoblast
Promegakaryocyte
Figure 16.12
95
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Developmental pathway
Hemocytoblast
Megakaryoblast
Promegakaryocyte
Megakaryocyte
Figure 16.12
96
Genesis of Platelets
The stem cell for platelets is the
hemocytoblast The sequential developmental
pathway is as shown.
Stem cell
Developmental pathway
Hemocytoblast
Megakaryoblast
Promegakaryocyte
Megakaryocyte
Platelets
Figure 16.12
97
Hemostasis
  • A series of reactions for stoppage of bleeding
  • During hemostasis, three phases occur in rapid
    sequence
  • Vascular spasms immediate vasoconstriction in
    response to injury
  • Platelet plug formation
  • Coagulation (blood clotting)

98
Platelet Plug Formation
  • Platelets do not stick to each other or to blood
    vessels
  • Upon damage to blood vessel endothelium
    platelets
  • With the help of von Willebrand factor (VWF)
    adhere to collagen
  • Are stimulated by thromboxane A2
  • Stick to exposed collagen fibers and form a
    platelet plug
  • Release serotonin and ADP, which attract still
    more platelets
  • The platelet plug is limited to the immediate
    area of injury by prostacyclin

99
Coagulation
  • A set of reactions in which blood is transformed
    from a liquid to a gel
  • Coagulation follows intrinsic and extrinsic
    pathways
  • The final three steps of this series of reactions
    are
  • Prothrombin activator is formed
  • Prothrombin is converted into thrombin
  • Thrombin catalyzes the joining of fibrinogen into
    a fibrin mesh

100
Coagulation
Figure 16.13a
101
Detailed Events of Coagulation
Figure 16.13b
102
Coagulation Phase 1 Two Pathways to Prothrombin
Activator
  • May be initiated by either the intrinsic or
    extrinsic pathway
  • Triggered by tissue-damaging events
  • Involves a series of procoagulants
  • Each pathway cascades toward factor X
  • Once factor X has been activated, it complexes
    with calcium ions, PF3, and factor V to form
    prothrombin activator

103
Coagulation Phase 2 Pathway to Thrombin
  • Prothrombin activator catalyzes the
    transformation of prothrombin to the active
    enzyme thrombin

104
Coagulation Phase 3 Common Pathways to the
Fibrin Mesh
  • Thrombin catalyzes the polymerization of
    fibrinogen into fibrin
  • Insoluble fibrin strands form the structural
    basis of a clot
  • Fibrin causes plasma to become a gel-like trap
  • Fibrin in the presence of calcium ions activates
    factor XIII that
  • Cross-links fibrin
  • Strengthens and stabilizes the clot

105
Clot Retraction and Repair
  • Clot retraction stabilization of the clot by
    squeezing serum from the fibrin strands
  • Repair
  • Platelet-derived growth factor (PDGF) stimulates
    rebuilding of blood vessel wall
  • Fibroblasts form a connective tissue patch
  • Stimulated by vascular endothelial growth factor
    (VEGF), endothelial cells multiply and restore
    the endothelial lining

106
Factors Limiting Clot Growth or Formation
  • Two homeostatic mechanisms prevent clots from
    becoming large
  • Swift removal of clotting factors
  • Inhibition of activated clotting factors

107
Inhibition of Clotting Factors
  • Fibrin acts as an anticoagulant by binding
    thrombin and preventing its
  • Positive feedback effects of coagulation
  • Ability to speed up the production of prothrombin
    activator via factor V
  • Acceleration of the intrinsic pathway by
    activating platelets

108
Inhibition of Clotting Factors
  • Thrombin not absorbed to fibrin is inactivated by
    antithrombin III
  • Heparin, another anticoagulant, also inhibits
    thrombin activity

109
Factors Preventing Undesirable Clotting
  • Unnecessary clotting is prevented by endothelial
    lining the blood vessels
  • Platelet adhesion is prevented by
  • The smooth endothelial lining of blood vessels
  • Heparin and PGI2 secreted by endothelial cells
  • Vitamin E quinone, a potent anticoagulant

110
Hemostasis DisordersThromboembolytic Conditions
  • Thrombus a clot that develops and persists in
    an unbroken blood vessel
  • Thrombi can block circulation, resulting in
    tissue death
  • Coronary thrombosis thrombus in blood vessel of
    the heart

111
Hemostasis DisordersThromboembolytic Conditions
  • Embolus a thrombus freely floating in the blood
    stream
  • Pulmonary emboli can impair the ability of the
    body to obtain oxygen
  • Cerebral emboli can cause strokes

112
Prevention of Undesirable Clots
  • Substances used to prevent undesirable clots
  • Aspirin an antiprostaglandin that inhibits
    thromboxane A2
  • Heparin an anticoagulant used clinically for
    pre- and postoperative cardiac care
  • Warfarin used for those prone to atrial
    fibrillation

113
Hemostasis Disorders
  • Disseminated Intravascular Coagulation (DIC)
    widespread clotting in intact blood vessels
  • Residual blood cannot clot
  • Blockage of blood flow and severe bleeding
    follows
  • Most common as
  • A complication of pregnancy
  • A result of septicemia or incompatible blood
    transfusions

114
Hemostasis Disorders Bleeding Disorders
  • Thrombocytopenia condition where the number of
    circulating platelets is deficient
  • Patients show petechiae due to spontaneous,
    widespread hemorrhage
  • Caused by suppression or destruction of bone
    marrow (e.g., malignancy, radiation)
  • Platelet counts less than 50,000/mm3 is
    diagnostic for this condition
  • Treated with whole blood transfusions

115
Hemostasis Disorders Bleeding Disorders
  • Inability to synthesize procoagulants by the
    liver results in severe bleeding disorders
  • Causes can range from vitamin K deficiency to
    hepatitis and cirrhosis
  • Inability to absorb fat can lead to vitamin K
    deficiencies as it is a fat-soluble substance and
    is absorbed along with fat
  • Liver disease can also prevent the liver from
    producing bile, which is required for fat and
    vitamin K absorption

116
Hemostasis Disorders Bleeding Disorders
  • Hemophilias hereditary bleeding disorders
    caused by lack of clotting factors
  • Hemophilia A most common type (83 of all
    cases) due to a deficiency of factor VIII
  • Hemophilia B due to a deficiency of factor IX
  • Hemophilia C mild type, due to a deficiency of
    factor XI

117
Hemostasis Disorders Bleeding Disorders
  • Symptoms include prolonged bleeding and painful
    and disabled joints
  • Treatment is with blood transfusions and the
    injection of missing factors

118
Blood Transfusions
  • Whole blood transfusions are used
  • When blood loss is substantial
  • In treating thrombocytopenia
  • Packed red cells (cells with plasma removed) are
    used to treat anemia

119
Human Blood Groups
  • RBC membranes have glycoprotein antigens on their
    external surfaces
  • These antigens are
  • Unique to the individual
  • Recognized as foreign if transfused into another
    individual
  • Promoters of agglutination and are referred to as
    agglutinogens
  • Presence or absence of these antigens is used to
    classify blood groups

120
Blood Groups
  • Humans have 30 varieties of naturally occurring
    RBC antigens
  • The antigens of the ABO and Rh blood groups cause
    vigorous transfusion reactions when they are
    improperly transfused
  • Other blood groups (M, N, Dufy, Kell, and Lewis)
    are mainly used for legalities

121
ABO Blood Groups
  • The ABO blood groups consists of
  • Two antigens (A and B) on the surface of the RBCs
  • Two antibodies in the plasma (anti-A and anti-B)
  • ABO blood groups may have various types of
    antigens and preformed antibodies
  • Agglutinogens and their corresponding antibodies
    cannot be mixed without serious hemolytic
    reactions

122
ABO Blood Groups
Table 16.4
123
Rh Blood Groups
  • There are eight different Rh agglutinogens, three
    of which (C, D, and E) are common
  • Presence of the Rh agglutinogens on RBCs is
    indicated as Rh
  • Anti-Rh antibodies are not spontaneously formed
    in Rh individuals
  • However, if an Rh individual receives Rh blood,
    anti-Rh antibodies form
  • A second exposure to Rh blood will result in a
    typical transfusion reaction

124
Hemolytic Disease of the Newborn
  • Hemolytic disease of the newborn Rh antibodies
    of a sensitized Rh mother cross the placenta and
    attack and destroy the RBCs of an Rh baby
  • Rh mother becomes sensitized when exposure to
    Rh blood causes her body to synthesize Rh
    antibodies

125
Hemolytic Disease of the Newborn
  • The drug RhoGAM can prevent the Rh mother from
    becoming sensitized
  • Treatment of hemolytic disease of the newborn
    involves pre-birth transfusions and exchange
    transfusions after birth

126
Transfusion Reactions
  • Transfusion reactions occur when mismatched blood
    is infused
  • Donors cells are attacked by the recipients
    plasma agglutinins causing
  • Diminished oxygen-carrying capacity
  • Clumped cells that impede blood flow
  • Ruptured RBCs that release free hemoglobin into
    the bloodstream

127
Transfusion Reactions
  • Circulating hemoglobin precipitates in the
    kidneys and causes renal failure

128
Blood Typing
  • When serum containing anti-A or anti-B
    agglutinins is added to blood, agglutination will
    occur between the agglutinin and the
    corresponding agglutinogens
  • Positive reactions indicate agglutination

129
Blood Typing
130
Plasma Volume Expanders
  • When shock is imminent from low blood volume,
    volume must be replaced
  • Plasma or plasma expanders can be administered

131
Plasma Volume Expanders
  • Plasma expanders
  • Have osmotic properties that directly increase
    fluid volume
  • Are used when plasma is not available
  • Examples purified human serum albumin,
    plasminate, and dextran
  • Isotonic saline can also be used to replace lost
    blood volume

132
Diagnostic Blood Tests
  • Laboratory examination of blood can assess an
    individuals state of health
  • Microscopic examination
  • Variations in size and shape of RBCs
    predictions of anemias
  • Type and number of WBCs diagnostic of various
    diseases
  • Chemical analysis can provide a comprehensive
    picture of ones general health status in
    relation to normal values
Write a Comment
User Comments (0)
About PowerShow.com